Pressure Biosciences, Inc. (PBIO) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-5.93M
Depreciation and amortization
Stock-based compensation expense	282.81K
Warrant income relating to revaluation
Bad debt expense
Short-term investments
Accounts receivable	-476.43K
Inventories	30.23K
Deposits
Accounts payable
Accrued employee compensation	9.9K
Deferred revenue and other accrued expenses	80.06K
Prepaid expenses and other current assets	33.95K
Net cash used in operating activities	-2.74M
Disposals/(Additions) to property and equipment	-3.27K
Net cash used in investing activities	-3.27K
Proceeds from stock option exercise
Decrease in restricted cash
Proceeds from stock warrant exercise
Net proceeds from the issuance of preferred stock
Net cash provided by financing activities	2.67M
Change in cash and cash equivalents	-74.84K
Cash and cash equivalents, beginning of period	116.78K
Cash and cash equivalents, end of period	41.94K
Income taxes paid
Issuance of common stock dividend on preferred stock
Issuance of common stock warrants for services
Issuance of common stock for services
Series B dividend paid in cash
Beneficial conversion feature on convertible preferred stock

Entities mentioned with PBIO

View All Entities